CAS 56632-39-4
:2H-Indolo-2-one, 1,3-diidro-3,3-bis(4-idrossifenil)-7-metil-
Ref: IN-DA00ECFD
100mgPrezzo su richiesta250mgPrezzo su richiesta5mg118,00€1mg124,00€10mg187,00€25mg240,00€50mg543,00€BHPI
CAS:Prodotto controllatoApplications BHPI is an antagonist of estrogen receptor α (ERα) that blocks 17β-estradiol-induced proliferation of drug-resistant breast, endometrial and ovarian cancer cell lines.
References Andruska, N. et al.: PNAC. Sci. U.S.A., 112, 4737 (2015);Formula:C21H17NO3Colore e forma:NeatPeso molecolare:331.37BHPI
CAS:BHPI is a non-selective cation that blocks the amp-activated protein kinase (AMPK) and thereby induces necrotic cell death. BHPI also inhibits the activity of fatty acid synthase, which is an enzyme involved in lipid synthesis. This inhibition results in the accumulation of lipids inside the cells, leading to necrosis. BHPI has been shown to inhibit cancer cell growth by inhibiting protein synthesis and inducing apoptosis. It also inhibits estrogen receptor-mediated signaling pathways, which prevents estrogen from binding to its receptors, thereby blocking the response pathway.
Formula:C21H17NO3Purezza:Min. 95%Peso molecolare:331.36 g/molBHPI
CAS:BHPI is a potent ERα inhibitor, activating UPR and blocking protein synthesis with an IC50 value. It depletes EnR Ca(2+) via PLCγ in ERα(+) cancer cells.Formula:C21H17NO3Colore e forma:SolidPeso molecolare:331.36



